The clinical significance of ApoE4 on brain integrity has been shown in studies of people with AD (Martins et al., 2005), those with mild cognitive impairment (Risacher et al., 2013), and the non-demented elderly (Bretsky et al., 2003; Wisdom et al., 2011). This evidence concerns the gene APOE and Alzheimer disease.